In addition, the stress caused by persistent night sweats can lead to elevated cortisol levels
In the SURPASS-2 trial, which compared tirzepatide to semaglutide 1 mg (a GLP-1 receptor agonist) over 40 weeks, participants receiving tirzepatide achieved A1C reductions of 2.01%, 2.24%, and 2.30% from baseline with the 5 mg, 10 mg, and 15 mg weekly doses, respectively
We also offer ongoing support and monitoring, including regular check-ins to assess progress and side effects, telemedicine options for convenient follow-ups, and access to a dedicated care team for questions and concerns
Discontinuation rates due to adverse events in TRIUMPH-3 were 9.8% (9 mg) and 13.5% (12 mg) with retatrutide, compared with 4.8% for placebo
It simultaneously activates three key metabolic receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide) and the receptor at glucagon This triple synergistic action makes it one of the most studied peptides in research on obesity and metabolic disorders